Dr. Cathy Knupp is executive vice president and president of Research and Development at Zoetis (formerly Pfizer Animal Health). Prior to that, Dr. Knupp served as vice president, Veterinary Medicine Research and Development at Pfizer Animal Health, a position she held since 2005. In her role, she is responsible for managing global R&D activities in support of discovering and registering medicines and vaccines to prevent disease in companion animals and livestock species, and improve health and optimize performance.
Prior to joining Pfizer Animal Health, Dr. Knupp led Pfizer's Michigan laboratories in pharmacokinetics, dynamics and metabolism, and chaired the Midwest Exploratory Development Management Team in Pfizer Global Research and Development.
She began her career in 1987 at Bristol-Myers Squibb where she held positions of increasing responsibility in drug metabolism and pharmacokinetics. This experience led to her appointment as executive director, Drug Metabolism and Pharmacokinetics. Her last position with that company was as vice president, Chemical Manufacturing Controls (CMC), where she was responsible for global CMC regulatory submissions.
Dr. Knupp earned her Doctor of Veterinary Medicine (DVM) degree in 1985 from the University of Illinois, where she also received a master's degree in toxicology and a bachelor's degree in veterinary biosciences. She also earned another bachelor's degree in chemistry from Western Illinois University.